137 related articles for article (PubMed ID: 18489529)
1. Fertility issues in patients with prostate cancer.
Steinsvik EA; Fosså SD; Lilleby W; Eilertsen K
BJU Int; 2008 Sep; 102(7):793-5. PubMed ID: 18489529
[TBL] [Abstract][Full Text] [Related]
2. Does brachytherapy of the prostate affect sperm quality and/or fertility in younger men?
Mydlo JH; Lebed B
Scand J Urol Nephrol; 2004; 38(3):221-4. PubMed ID: 15204375
[TBL] [Abstract][Full Text] [Related]
3. Testicular dose in prostate cancer radiotherapy: impact on impairment of fertility and hormonal function.
Boehmer D; Badakhshi H; Kuschke W; Bohsung J; Budach V
Strahlenther Onkol; 2005 Mar; 181(3):179-84. PubMed ID: 15756522
[TBL] [Abstract][Full Text] [Related]
4. Fertility issues for men with newly diagnosed prostate cancer.
Knoester PA; Leonard M; Wood DP; Schuster TG
Urology; 2007 Jan; 69(1):123-5. PubMed ID: 17270632
[TBL] [Abstract][Full Text] [Related]
5. Radiation dose predicts for biochemical control in intermediate-risk prostate cancer patients treated with low-dose-rate brachytherapy.
Ho AY; Burri RJ; Cesaretti JA; Stone NN; Stock RG
Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):16-22. PubMed ID: 19289266
[TBL] [Abstract][Full Text] [Related]
6. Population-based study of biochemical and survival outcomes after permanent 125I brachytherapy for low- and intermediate-risk prostate cancer.
Morris WJ; Keyes M; Palma D; Spadinger I; McKenzie MR; Agranovich A; Pickles T; Liu M; Kwan W; Wu J; Berthelet E; Pai H
Urology; 2009 Apr; 73(4):860-5; discussion 865-7. PubMed ID: 19168203
[TBL] [Abstract][Full Text] [Related]
7. Multicenter analysis of effect of high biologic effective dose on biochemical failure and survival outcomes in patients with Gleason score 7-10 prostate cancer treated with permanent prostate brachytherapy.
Stone NN; Potters L; Davis BJ; Ciezki JP; Zelefsky MJ; Roach M; Shinohara K; Fearn PA; Kattan MW; Stock RG
Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):341-6. PubMed ID: 18597953
[TBL] [Abstract][Full Text] [Related]
8. Conservative surgery plus brachytherapy treatment for boys with prostate and/or bladder neck rhabdomyosarcoma: a single team experience.
Martelli H; Haie-Meder C; Branchereau S; Franchi-Abella S; Ghigna MR; Dumas I; Bouvet N; Oberlin O
J Pediatr Surg; 2009 Jan; 44(1):190-6. PubMed ID: 19159742
[TBL] [Abstract][Full Text] [Related]
9. High-dose-rate brachytherapy for localized prostate adenocarcinoma post abdominoperineal resection of the rectum and pelvic irradiation: Technique and experience.
Jabbari S; Hsu IC; Kawakami J; Weinberg VK; Speight JL; Gottschalk AR; Roach M; Shinohara K
Brachytherapy; 2009; 8(4):339-44. PubMed ID: 19428310
[TBL] [Abstract][Full Text] [Related]
10. External beam radiotherapy for clinically localized hormone-refractory prostate cancer: clinical significance of Nadir prostate-specific antigen value within 12 months.
Ogawa K; Nakamura K; Sasaki T; Onishi H; Koizumi M; Shioyama Y; Araya M; Mukumoto N; Mitsumori M; Teshima T;
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):759-65. PubMed ID: 19327908
[TBL] [Abstract][Full Text] [Related]
11. Radiation therapy for prostate cancer increases subsequent risk of bladder and rectal cancer: a population based cohort study.
Nieder AM; Porter MP; Soloway MS
J Urol; 2008 Nov; 180(5):2005-9; discussion 2009-10. PubMed ID: 18801517
[TBL] [Abstract][Full Text] [Related]
12. Excellent results from high dose rate brachytherapy and external beam for prostate cancer are not improved by androgen deprivation.
Demanes DJ; Brandt D; Schour L; Hill DR
Am J Clin Oncol; 2009 Aug; 32(4):342-7. PubMed ID: 19398902
[TBL] [Abstract][Full Text] [Related]
13. Variations in international prostate symptom scores, uroflowmetric parameters, and prostate volume after (125)I permanent brachytherapy for localized prostate cancer.
Tanaka N; Fujimoto K; Hirao Y; Asakawa I; Hasegawa M; Konishi N
Urology; 2009 Aug; 74(2):407-11. PubMed ID: 19376570
[TBL] [Abstract][Full Text] [Related]
14. An eight-year experience of HDR brachytherapy boost for localized prostate cancer: biopsy and PSA outcome.
Bachand F; Martin AG; Beaulieu L; Harel F; Vigneault E
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):679-84. PubMed ID: 18963537
[TBL] [Abstract][Full Text] [Related]
15. [Chronic gastrointestinal toxicity after external-beam radiation therapy for prostate cancer].
Sefrová J; Paluska P; Odrázka K; Jirkovský V
Klin Onkol; 2009; 22(5):233-41. PubMed ID: 19886362
[TBL] [Abstract][Full Text] [Related]
16. Hypofractionated boost with high-dose-rate brachytherapy and open magnetic resonance imaging-guided implants for locally aggressive prostate cancer: a sequential dose-escalation pilot study.
Ares C; Popowski Y; Pampallona S; Nouet P; Dipasquale G; Bieri S; Ozsoy O; Rouzaud M; Khan H; Miralbell R
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(3):656-63. PubMed ID: 19250768
[TBL] [Abstract][Full Text] [Related]
17. [Fertility after prostate brachytherapy with Iode 125 permanent implants for localized prostate cancer].
Delaunay B; Delannes M; Bachaud JM; Bouaziz M; Salloum A; Thoulouzan M; Soulié M; Plante P; Huyghe E
Prog Urol; 2012 Jan; 22(1):53-7. PubMed ID: 22196006
[TBL] [Abstract][Full Text] [Related]
18. Four-year experience of interstitial permanent brachytherapy for Japanese men with localized prostate cancer.
Ishiyama H; Satoh T; Kitano M; Tsumura H; Kotani S; Okusa H; Uemae M; Baba S; Hayakawa K
Jpn J Clin Oncol; 2008 Jul; 38(7):469-73. PubMed ID: 18577509
[TBL] [Abstract][Full Text] [Related]
19. Survivorship beyond convalescence: 48-month quality-of-life outcomes after treatment for localized prostate cancer.
Gore JL; Kwan L; Lee SP; Reiter RE; Litwin MS
J Natl Cancer Inst; 2009 Jun; 101(12):888-92. PubMed ID: 19509365
[TBL] [Abstract][Full Text] [Related]
20. High dose rate and external beam radiotherapy in locally advanced prostate cancer.
Viani GA; Pellizzon AC; Guimarães FS; Jacinto AA; dos Santos Novaes PE; Salvajoli JV
Am J Clin Oncol; 2009 Apr; 32(2):187-90. PubMed ID: 19307949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]